February 2017 issue
January 2017 issue
December 2013 Issue
New Drug Review: Dabrafenib mesylate (Tafinlar)
New Drug Review: Trametinib dimethyl sulfoxide (Mekinist)
Index for 2013
November 2013 Issue
Feature - Inspiration!
New Drug Review: Crofelemer (Fulyzaq)
October 2013 Issue
Feature - Obtaining Health Insurance that Isn't Understood Using a System that Isn't Working - And the Situation Will Get Worse if there is not Compromise!
New Drug Review: Ospemifene (Osphena)
September 2013 Issue
Feature - Boards of Pharmacy Should Discontinue Issuing Licenses to Pharmacies that Sell Tobacco Products and to Pharmacies that are in Facilities that Sell Tobacco Products
New Drug Review: Vilanterol trifenatate/fluticasone furoate (Breo Ellipta)
August 2013 Issue
Feature - Mail-order Pharmacy Threatens the Role of Pharmacists as Health Professionals
New Drug Review: Dimethyl fumarate (Tecfidera)
July 2013 Issue
Feature - Pharmacists Be On Guard! For the Protection of Your Patients and Yourselves
New Drug Review: Lorcaserin (Belviq)
June 2013 Issue
Feature - Walgreens Challenges CVS in the Race to the Bottom - But No Individuals are Accountable!
New Drug Review: Alogliptin benzoate (Nesina)
May 2013 Issue
Feature - Pfizer's Viagra Promotion Puts Patients at Risk and is an Insult to Local Pharmacists
New Drug Review: Canagliflozin (Invokana)
April 2013 Issue
Feature - Pharmacy as a Career Choice? YES!
New Drug Review: Apixaban (Eliquis)
March 2013 Issue
Feature - "I Quit CVS Today"
New Drug Review: Linaclotide (Linzess)
February 2013 Issue
Feature - Express Scripts Almost Discovers Conscience - But Fails to Do So!
New Drug Review: Teriflunomide (Aubagio)
January 2013 Issue
Feature - The APhA and ASHP Should Merge!
New Drug Review: Aclidinium bromide (Tudorza Pressair)
New Therapeutic Agents Marketed in the United States in 2012 (Table)